Cannabis Bioscience International Holdings reported a gross margin of 72.82% and a net margin of -928.47% for the quarter ended Feb 2026. These financial ratios cover 14 quarters of results from Nov 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||
| Gross Margin | 91.41% | 52.94% | 65.51% | 87.89% | 76.33% | 67.57% | 86.98% | 95.33% | 89.49% | -29.90% | 87.00% | 66.35% | 80.29% | 72.82% |
| EBT Margin | -266.27% | -633.45% | -594.90% | -249.64% | -195.19% | -574.53% | -164.69% | -55.87% | -95.39% | -1,016.05% | -679.85% | -380.79% | -213.53% | -928.47% |
| EBIT Margin | -222.34% | -555.81% | -592.30% | -242.77% | -148.26% | -439.35% | -39.06% | -54.56% | -80.31% | -865.54% | -385.91% | -309.02% | -180.00% | -832.30% |
| EBITDA Margin | -222.34% | -555.81% | -592.30% | -242.77% | -148.26% | -439.35% | -39.06% | -54.56% | -80.31% | -865.54% | -385.91% | -309.02% | -180.00% | -832.30% |
| Operating Margin | -222.34% | -555.81% | -592.30% | -242.77% | -148.26% | -439.35% | -39.06% | -54.56% | -80.31% | -865.54% | -385.91% | -309.02% | -180.00% | -832.30% |
| Net Margin | -266.27% | -633.45% | -594.90% | -249.64% | -195.19% | -574.53% | -164.69% | -55.87% | -95.39% | -1,016.05% | -679.85% | -380.79% | -213.53% | -928.47% |
| FCF Margin | -392.53% | -404.75% | -102.47% | -347.07% | -24.93% | -229.94% | -17.00% | -97.09% | -554.63% | -412.84% | -428.56% | -10.31% | -130.27% | |
| Efficiency | ||||||||||||||
| Assets AverageAssets Avg. | 0.10M | 0.08M | 0.05M | 0.04M | 0.02M | 0.02M | 0.03M | 0.02M | 0.01M | |||||
| Invested CapitalInvested Cap. | -0.21M | -0.43M | -0.57M | -0.69M | -0.69M | -0.76M | -0.84M | -0.79M | -0.87M | -0.99M | -1.09M | |||
| Asset Utilization RatioAsset Util. | 2.24 | 3.29 | 6.86 | 9.02 | 13.85 | 12.96 | 5.84 | 6.20 | 10.44 | |||||
| Leverage & Solvency | ||||||||||||||
| Interest Coverage RatioInterest Cover | -5.06 | -7.16 | -227.94 | -35.32 | -3.16 | -3.25 | -0.31 | -41.73 | -5.32 | -5.75 | -1.31 | -4.31 | -5.37 | -8.65 |
| Debt Ratio | 8.89 | 4.05 | 4.34 | 6.87 | 7.98 | 10.84 | 26.12 | 11.79 | 19.84 | 16.98 | 243.40 | |||
| Times Interest Earned | -5.06 | -7.16 | -227.94 | -35.32 | -3.16 | -3.25 | -0.31 | -41.73 | -5.32 | -5.75 | -1.31 | -4.31 | -5.37 | -8.65 |
| Return Ratios | ||||||||||||||
| Return on Sales [ROS]ROS | -222.34% | -555.81% | -592.30% | -242.77% | -148.26% | -439.35% | -39.06% | -54.56% | -80.31% | -865.54% | -385.91% | -309.02% | -180.00% | -832.30% |
| Return on Capital Employed [ROCE]ROCE | 100.43% | 57.16% | 47.69% | 41.68% | 33.44% | 45.67% | 40.25% | 38.98% | 33.03% | |||||
| Return on Assets [ROA]ROA | -808.43% | -847.38% | -1,079.83% | -1,245.95% | -1,802.20% | -2,395.44% | -2,173.61% | -2,898.47% | -4,625.75% |